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Skeletal resistance to the calcemic action of PTH in uremia: Role
of 1,25(OI-1)2D3. Studies were carried Out to investigate the role of
1,25 dihydroxy vitamin D [l,25(OH)2D3J in the skeletal resistance
to the calcemic action of parathyroid hormone. The change in
serum calcium after the intravenous infusion of 2 U of parathyroid
extract (PTE)/kg body wt/hr for eight hours was evaluated in
thyroparathyroidectomized (T-PTX) dogs before, and one, two
and three days after, induction of uremia by bilateral ureteral
ligation (Il dogs) or by bilateral nephrectomy (8 dogs). In another
six nephrectomized and T-PTX dogs, 0.68 jg of 1 ,25(OH)2D3/day
was given on the day of nephrectomy and for two days thereafter.
Serum creatinine in each day of the study was not different among
the three groups. The study also included the evaluation of the
effect of sham operation (five dogs) and the administration of
I ,25(OH )2D3 to dogs with normal renal function (four dogs) on the
calcemic response to PTE, as well as the reproducibility of such a
response in the same animal. The results showed that /) the
calcemic response to PTE was markedly impaired after one day of
bilateral ureteral ligation or nephrectomy, but the impairment was
more severe after nephrectomy; 2) the calcemic response to PTE
after two or three days of bilateral ureteral ligation was similar to
that seen at one day after nephrectomy; 3) l,25(OH)2D3 partially
restored the calcemic response to PTE in the nephrectomized ani-
mals to levels similar to those seen after one day of bilateral
ureteral ligation; 4) sham operation did not affect the response to
PTE, and repeated infusion of PTE produced similar changes in
the concentrations of serum calcium. The data indicate that (a) a
deficiency of l,25(Ol-I)2D3 is at least partly responsible for the
skeletal resistance to the calcemic action of PTH in uremia; (b)
uremia, per se, may also contribute to this phenomenon; and (c)
the kidney after one day of complete bilateral ureteral ligation may
still produce l,25(OH)2D3, but this ability is compromised after
two days of ureteral obstruction.
Résistance de l'os I l'action hypercalcémiante de Ia PTH au cours
de l'urémie: Role du 1,25-(OH)2D3. Ce travail a pour but d'étudier
le role de Ia 1,25 dihydroxy vitamine D (l,25-(Ol-1)2D3) dans Ia
résistance de l'os a l'action hypercalcémiante de l'hormone para-
thyroldienne. Les modifications du calcium du plasma après Ia
perfusion intra-veineuse de 2 U d'extrait parathyroIdien (PTE)/kg
de poids corporel/heure pendant 8 heures ont. été mesurées chez
des chiens thyroparathyroldectomisés (T-PTX) avant puis 1,2 et
3 jours après I'induction de l'urémie par ligature bilatérale des
uretères (II chiens) ou néphzectomie bilatérale (8 chiens). A un
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autre groupe de 6 chiens néphrectomisés et T-PTX, 0,68 .sg de
I,25(OH)2D3 ont été administrés Ic jour de Ia néphrectomie et les
deux jours suivants. La créatinine plasmatique a chaque jour de
I'étude était le même dans les trois groupes. Le travail a aussi
évalué les effets d'un simulacre d'opération (5 chiens) et de
l'administration de l,25-(OH)2D3 a des chiens ayant une fonction
rénale normale (4 chiens) sur Ia réponse de Ia calcémie au PTE
ainsi que Ia reproductibilité de Ia réponse chez Ic même animal. Les
résultats montrent que: I) Ia réponse calcémique au PTE est altérée
de facon importante 24 heures aprés Ia ligature urétérale ou Ia
néphrectomie, I'altération est plus grande aprés néphrectomie; 2)
Ia réponse calcémique au PTE après deux et troisjours de ligature
urétérale est semblable a celle observée après un jour de néphrec-
tomie; 3) Ic l,24(OH)2D3 restaure partiellement Ia réponse calcé-
mique au PTE chez les animaux néphrectomisés, Ia réponse ob-
tenue est semblable a celle observée après un jour de ligature
urétérale bilatérale; 4) Ic simulacre d'opération n'affecte pas Ia
réponse au PTE et les perfusions répétées de PTE produisent des
modifications similaires de Ia concentration plasmatique de cal-
cium. Ccs résultats sont compatibles avec les interpretations sui-
vantes: a) un deficit de l,25-(OH)2D3 est, au moms en partie,
responsable de Ia résistance osseuse a I'action hypercalcemiante de
Ia PTH au cours de l'urémie, b) l'urémie, par elle-même, peut aussi
contribuer a cette modification et c) le rein peut encore produire du
l,25-(Ol-i)2D3 aprés un jour de ligature urétérale bilatérale mais
cette capacité est abolie après deux jours d'obstruction urétérale.
Skeletal resistance to the calcemic action of both
exogenous and endogenous parathyroid hormone
(PTH) has been demonstrated in patients with acute
renal failure [1] and in those with mild and advanced
renal failure [2—4J. This impaired calcemic response
to PTH could be partly responsible for the hypocal-
cemia of renal failure and, therefore, contribute to
the development of secondary hyperparathyroidism
in patients with renal insufficiency [3,4]. The under-
standing of the mechanism(s) underlying this abnor-
mality may help provide a rational approach to the
prevention and management of the secondary hy-
perparathyroidism commonly found in patients with
renal failure.
It has been shown that the active metabolite 1,25
dihydroxyvitamin D3 [1,25(OH)2D3J is produced by
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the kidney from the parent vitamin [5—71. A defi-
ciency of 1,25(OH)2D3 could, therefore, occur in pa-
tients with renal failure. Indeed, Brumbaugh et al
reported very low concentrations of l,25(OH)2D3 in
such patients [81. Since vitamin D may play a per-
missive role in the action of PTH on bone [9], it is
possible that a deficiency in l,25(OH)2D3 is, partially
or totally, responsible for the skeletal resistance to
PTH in patients with renal failure. The present in-
vestigation was undertaken to evaluate the role of
1,25(OH)2D3 in this abnormality.
Methods
Thirty-nine male or female mongrel dogs weighing
17 to 20 kg were studied. They received the same diet
(Purina Chow) throughout the entire study. The dogs
were first subjected to thyroparathyroidectomy (1-
PTX). The success of the surgical procedure was
ascertained by a fall in the blood concentrations of
calcium of at least 1.5 to 2.0 mg/l00 ml. Control
studies were carried out three to four days after T-
PTX to evaluate the changes in the concentration of
serum calcium produced by a standard infusion of
parathyroid extract (PTE) (Eli Lilly, Indianapolis,
Indiana). Parathyroid extract, 2U/kg/hr, was infused
for eight hours, and the calcemic response was deter-
mined. The same batch of PTE was used in all stud-
ies. All experiments were performed with the animals
in the awake state and standing in loosely fitting
canvas slings. The animals were not permitted to eat
during the study. Venous blood samples were ob-
tained from an indwelling needle inserted into ajugu-
lar vein. Three samples were obtained every 15 mm
prior to the infusion of PTE and hourly for eight
hours thereafter. The calcemic response to the PTE
infusion was calculated from the difference between
the mean value of serum calcium noted in the three
control samples and the highest value observed at
seven or eight hours of the infusion.
Acute uremia was produced either by bilateral ure-
teral ligation (11 dogs) or by bilateral nephrectomy
(14 dogs) utilizing standard surgical procedures. The
calcemic response to the standard PTE infusion was
evaluated before, and one, two and three days after,
the induction of uremia. Six of the bilaterally ne-
phrectomized dogs received 0.68 g of l,25(OH)2D3
intravenously on the day of the nephrectomy and for
three days thereafter. To investigate the possibility
that the administration of 1,25(0H)2D3 to T-PTX
dogs might affect the calcemic response to PTE in the
absence of uremia, four T-PTX animals with normal
renal function received the standard PTE infusion
before, and one and three days after, intravenous
administration of 0.68 tg of 1,25(OH)2D3 per day.
The 1,25(0 H )2D3 was prepared biosynthetically
according to the method of Norman et at [7],
whereby 25-dihydroxy-26,27-3H cholecalciferol, di-
luted with unlabeled 25-hydroxycholecalciferol, is in-
cubated with homogenates prepared from kidneys of
three-week-old rachitic chicks. Medium from rep-
licate incubations was pooled and extracted with
chloroform and methanol, 1:2 vol/vol. After re-
moval of the organic solvent in vacuo, the lipid resi-
due was dissolved in diethyl ether and separated with
silicic acid chromatography. Columns were eluted suc-
cessively with 100% ether-diethyl ether and dichlo-
roethane 1: 1 vol/vol, and, finally, 100% methanol.
Fractions identified as containing the l,25(0H)2aH
D3 were pooled, dissolved in hexane and chloroform,
0.65:0.35 vol/vol, and further purified by chromatog-
raphy on a column containing Sephadex, LH-20.
The fractions from this latter column containing
1,25(OH)2-3H-D3 were identified, pooled and dis-
solved in small volumes of methanol, and stored in
the dark at —5°C. Each batch of l,25(OH)2D3 was
shown to be highly biologically active by its effect
of stimulating intestinal absorption of 45Ca in vivo
in rachitic chicks [10]. The final concentration of
1,25(0 H )2-H-D3 was determined from measurement
of radioactivity in small aliquots of the final material
and from knowledge of the specific activity of 25-
(OH)-26,273H-D3, used in the initial incubation.
Five T-PTX dogs were operated in the abdominal
region and the calcemic response to the standard
infusion of PTE was evaluated before and one day
after sham operation. In order to investigate the re-
producibility of the rise in serum calcium by PTE in
the same animal, five T-PTX dogs, without uremia,
received two PTE infusions separated by three-day
intervals.
Res&ts
Animals with bilateral ureteral ligation (Table 1,
Fig. 1). Prior to the induction of uremia, the infusion
of PTE produced a rise in serum calcium of 1.19 to
2.85 mg/lOU ml with a mean of 1.84 + 0.18 (SE)
mg/lOO ml. After one day of uremia (serum creati-
nine, 5.4 + 0.22 mg/l00 ml), the increment in serum
calcium after PTE infusion was lower in every animal
and ranged between 0.83 and 1.61 mg/l00 ml with a
mean of 1.07 0.11 mg/l00 ml; this increment is
significantly less than the control (P < 0.01) and
constitutes 56.1 2.60% of the change in serum
calcium observed before uremia. There was a further
reduction in the calcemic response to PTE as the
duration of uremia was prolonged. The mean rise in
serum calcium was 0.40 0.19 mg/lOU ml after two
days of uremia and 0.50 0.08 mg/lOU ml after three
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days of uremia; the changes in these two days are
not different statistically, and they constitute 21.5
7.94% and 27.1 + 3.8% of the changes in serum
calcium observed before the ureteral ligation.
Animals with bilateral nephrectomy (Table 2, Fig.
2). The infusion of PTE before bilateral nephrectomy
raised serum calcium by 1.18 to 2.44 mg/100 ml with
a mean of 1.76 0.14 mg/100 ml. After one day of
uremia (serum creatinine, 5.4 0.26 mg/tOO ml),
there was a marked impairment in the calcemic re-
sponse to PTE. The rise in serum calcium ranged
between 0.02 and 0.63 mg/100 ml with a mean of 0.37
+ 0.10 mg/100 ml. This value is significantly lower
than both the changes observed in the control day (P
< 0.001) and also that noted after one day of uremia
in dogs with bilateral ureteral ligation (P < 0.001).
After three days of uremia in the nephrectomized
dogs, the increment in serum calcium in response to
PTE infusion (0.39 + 0.07 mg/100 ml) was not diffe-
rent from that seen after one day of uremia. The
increments in serum calcium after one and three days
of uremia constitute 20.5 + 4.2 1% and 20.5 + 5.75%
of the changes in the control day, respectively.
A nimals with bilateral nephrectomy receiving 1,25
(OH)2D3 (Table 3, Fig. 3). In this group of animals,
the infusion of PTE prior to nephrectomy and admin-
istration of 1,25(OH)2D3 increased serum calcium by
1.28 to 2.29 mg/l00 ml with a mean of 1.86 0.16
mg/l00 ml. The supplementation of 1,25(OH)2D3 at
the day of nephrectomy and thereafter improved the
calcemic response to PTE infusion, but the change in
serum calcium remained significantly lower than that
observed in the control day. After one day of uremia
(serum creatinine, 5.8 0.27 mg/100 ml), PTE infu-
sion caused a rise in serum calcium of 0.72 to 1.20
3.0
$
5
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:
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•
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Control 1 2 3
Days after BUL
Fig. 1. The changes in the concentration of seru.m calcium produced
by PTE infusion before, and after one, two and three days of
bilateral ureteral ligation (BUL). Each point represents one study;
the brackets denote one standard error.
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mg/100 ml with a mean of 1.10 0.11 mg/l00 ml.
This value constitutes 61.7 5.87% of the control rise
.in serum calcium and is not different from that seen
after one day of uremia in animals with bilateral
ureteral ligation. These nephrectomized dogs receiv-
'0C.)r)'.0CCC
oe . — r—COn 00 1- r r— C- r-
. .
ing 1,25(OH)2D3 displayed no further impairment in
the calcemic response to PTE after three days of
uremia; the increment in serum calcium ranged be-
00 '.0 '.0 '.0 'Or—
tween0.77and 1.6Omg/lOOmlwithamean of 1.07
0.14 mg/l00 ml. This value is not different from that
observed after one day of uremia and constitutes 54.2
+ 4.37% of the control increments in serum calcium.
The administration of l,25(OH)2D3 to T-PTX dogs
without uremia did not affect the response to PTE
(Table 4). In contrast to the uremic animals, adminis-
tration of 1,25(OH)2D3 to T-PTX dogs with normal
renal function produced progressive rise in the base-
line concentrations of serum calcium.
Effect of sham operation and evaluation of the repro-
ductability of the calcemic response (Tables 5 and 6).
Abdominal sham operation did not influence the cal-
C000CC'.000 cemic response to PTE. The increment in serum cal-,
cium was 1.83 + 0.15 mg/100 ml before and 1.82 +
0.12 mg/100 ml one day after surgery (Table 5). These
00 00
C .-———— C — — '
—
t
.E
0
studies of repeated PTE infusion demonstrate that
the calcemic response in the same animal is reproduc-
ible (Table 6).
The concentrations of serum phosphorus decreased
during the infusion of PTE to dogs with normal renal
function, while serum phosphorus did not change or
increase in animals with renal failure.
C.) r) . '.0
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Discussion
The results of the present studies confirm previous
observations in humans with acute renal failure [1]
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Table 4. Effect of parathyroid extract infusion before and after administration of 1,25 dihydroxycholecalciferol [1, 25(OH)2D3]
in thyroparathyroidectomized dogs with normal renal function
Sea SP
mg/lOU ml mg/tOO ml
Scr Sca
Dog no. mg/lOOm! B A mg/lOOm! B A
26 Control 1.0 5.37 7.54 2.17 7.2 3.2
Day 1 [1, 25(OH)2D31 1.0 6.10 8.54 2.44 5.1 2.8
Day 3 Il, 25(OH)2D3] 0.9 7.45 9.66 2.21 4.7 3.4
27 Control 0.9 6.44 9.18 2.74 4.3 2.8
Day 1 [1, 25(OH)2D31 0.8 7.48 10.00 2.52 4.7 2.7
Day 3 l, 25(OH)2D3] 0.9 9.99 12.60 2.61 4.7 4.3
28 Control 0.8 6.89 8.70 1.81 4.0 3.5
Day 1 [1, 25(OH)2D3] 0.9 7.36 9.40 2.04 4.3 3.5
Day 3 [I, 25(OH)2D3J 0.9 8.10 10.25 2.15 4.8 3.2
29 Control 0.9 4.69 6.62 1.93 4.3 2.2
Day I [I, 25(OH)2D3] 0.9 4.48 6.50 2.02 4.0 2.6
Day 3 [1, 25(OH)2D3} 1.0 8.70 10.92 2.13 4.6 3,2
Mean
Control 0.9 * .04 5.85 .50 8.01 + .58 2.16 .21 5.0 .75 2.9 .28
Day 1 [1, 25(OH)2D3] 0.9 .04 6.36 * .70 8.61 .76 2.26 + .13 4.5 .24 2.9 + .21
Day 3 [1, 25(OH)2D3] 0.9 .03 8.56 .54 10.86 * .64 2.28 .11 4.7 .04 3.5 2.6
Abbreviations as in Table 1.
ion in the media bathing culture of fetal rat bone can [12]. It seems unlikely that there could have been
block the calcium mobilizing effect of PTH [11], accumulation of excess osteoid in an amount ade-
Evanson reported that the calcemic response to PTE quate to alter the response to PTE during the very
in uremic patients with serum calcium concentrations short period of acute renal failure in the present
below 7.0 mg/l00 ml was less than that observed in study.
patients without such hypocalcemia [2]. The observa- It is well documented that the conversion of the
tion of Evanson has not been confirmed by others [3], parent vitamin D to its active metabolite, 1 ,25(OH)2D3,
and the difference might have been due to the pres- occurs in the kidney [5—7]. Nephrectomized vitamin-
ence of osteomalacia in Evanson's patients. In the D-deficient rats cannot produce l,25(OH)2D3 from
present study, however, there were no significant cholecalciferol [5, 13]. In contrast, rats with bilateral
differences in the concentration of serum calcium ureteral ligation and comparable degree of uremia
before and after the induction of uremia. may produce 1,25(OH)2D3, but the data indicate
Osteomalacia may render the skeleton unrespon- that there is quantitative deficiency of the hormone
sive to the calcemic action of PTH, presumably be- under these experimental conditions [13, 14]. It is
cause of accumulation of osteoid over bone surfaces reasonable, therefore, to suggest that the impaired
Table 5. Effect of parathyroid extract infusion before and after abdominal sham operation
in thyroparathyroidectomized dogs
Sea, mg/l00 ml
Dog no. Scr, mg/IOO ml B A Sca, mg/lOO ml
30 Control 1.1 5.74 7.50 1.76
Sham 1.0 5.59 7.24 1.65
31 Control 0.9 5.13 6.59 1.46
Sham 1.0 5.23 6.86 1.53
32 Control 0.8 6.22 8.56 2.34
Sham 0.9 6.10 8.25 2.15
33 Control 0.9 7.17 9.13 1.96
Sham 0.9 6.85 8.90 2.05
34 Control 1.0 5.94 7.59 1.65
Sham 0.9 6.15 7.89 1.74
Mean + SE
Control 0.9 .05 6.1 .33 7.9 + .44 1.83 .150
Sham 0.9 .02 6.0 .28 7.8 + .36 1.82 * .118
Abbreviations as in Table 1.
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Table 6. Effect of two parathyroid extract infusions given three days apart to thyroparathyroidectomized
dogs with normal renal function
Dog no. Scr,mg/IOOml
Sca
mg/100 ml
Sca,mg/lOOmlB A
35 1st PTE infusion
2nd PTE infusion
0.8
0.8
6.58
6.83
7.96
8.29
1.38
1.46
36 lstPTEinfusion
2nd PTE infusion
1.0
0.9
6.12
6.42
8.22
8.43
2.10
2.01
37 lstPTEinfusion
2nd PTE infusion
1.0
1.0
7.22
7.14
8.85
8.86
1.63
1.72
38 1st PTE infusion
2nd PTEinfusion
0.8
0.9
5.96
6.17
8.29
8.39
2.33
2.17
39 1st PTE infusion
2nd PTE infusion
0.9
1.0
6.89
6.48
8.71
8.37
1.82
1.89
Mean SE
0.9 + .04
0.9 .04
6.6 .23
6.6 .17
8.4 .16
8.5 .10
1.85 + .167
1.85 + .122
1st PTE infusion
2nd PTE infusion
Abbreviations as in Table 1.
E
2.0
E
+
A A AA
11.0
the level of serum phosphorus as shown in Fig. 4.
One may speculate that the blood concentrations of
l,25(OH)2D3 after one day of bilateral nephrectomy
were decreased and also were lower than those after
one day of bilateral ureteral ligation. In order for this
to occur, one should assume a very rapid turnover of
l,25(OH)2D3. Data on the half-life of this metabolite
are not adequate, but it has been estimated-to be one
day or shorter [15—16].
Second, the deterioration of the calcemic response
to PIE infusion after two or three days of bilateral
ureteral ligation to a magnitude not different from
that after one or three days of bilateral nephrectomy
is consistent with the kidneys being unable to pro-
duce adequate amounts of l,25(OH)2D3 after two
or three days of bilateral ureteral ligation. Finally,
the improvement in the calcemic response to PIE
in nephrectomized dogs after supplementation with
l,25(OH)2D3 cannot be attributed to variation in the
• BNX
o BNX + 1,25(01-1)203
calcemic response to PIE in our acutely uremic dogs
is, at least partly, due to a partial or an absolute
deficiency of 1,25(OH)2D3. Several lines of evidence
support this postulate.
First, the calcemic response to PIE after one day
of bilateral nephrectomy was more impaired than
after one day of bilateral ureteral ligation. Ihis diffe-
rence could not be due to variations in the degree of
uremia, since the blood concentrations of serum
creatinine were not different in the two groups of
animals; also, it could not be due to variations in
3.0
BUL
A BNX
E
2.0
+
1.0
o-,'/-- AA
Serum phosphorus, mq/lOO ml
Fig. 4. The relationship between the changes in the concentration of
serum calcium produced by PTE infusion and levels of serum phos-
phorus in dogs after one day of bilateral ureteral ligation () or one
day of bilateral nephrectomy (A).
A
E 0-0)
C,, 4 6 8 10 12 14 16 18 20
Serum phosphorus, mg/lOOm!
Fig. 5. The relationship between the changes in concentrations of
serum calcium produced by PTE infusion and concentrations of
serum phosphorus in nephrectomized dogs with (0) and without (•)
supplementation with 1,25(OH)2D3.
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degree of uremia (Tables 2 and 3) or to variations in
the magnitude of hyperphosphatemia (Fig. 5).
It is of interest that the administration of 1,25
(OH)2D3 to dogs with normal renal function did not
alter the calcemic response to PTE. This observa-
tion suggests that a role of l,25(OH)2D3 in the cal-
cemic response to PTH could be demonstrated only
in states where the metabolite is deficient or its action
on target organs is interfered with by other factors.
The present study was not designed to evaluate the
role of uremia, per Se, in the skeletal resistance to the
calcemic action of PTH; however, the results suggest
that uremia may be partly responsible for this abnor-
mality. The observation that supplementation of a
pharmacological dose of 1,25(OH)2D3 (0.68 gig/day
for a 20-kg dog) did not restore the calcemic response
to normal but only to levels similar to those observed
after one day of bilateral ureteral ligation suggests
that uremia, per se, may interfere with action of
l,25(OH)2D3 on its target organs. Other data also
indicate that uremia may interfere with the action of
l,25(OH)2D3 in another target organ, the intestine
[14, 17, 18].
Although the differences between the increments
in serum calcium following PTE infusion observed
in uremic animals after one day of bilateral ne-
phrectomy or bilateral ureteral ligation cannot be at-
tributed to variations in the concentration of serum
phosphorus (Figs. 3 and 4), it is still possible that
hyperphosphatemia, per se, may contribute to the
impaired calcemic response to PTH. The present
study was not planned to investigate the role of hy-
perphosphatemia in this abnormality, and further
studies are required to evaluate this issue. However,
studies in patients with acute renal failure have dem-
onstrated the presence of skeletal resistance to the
calcemic action of PIE whether the levels of serum
phosphorus were normal or high [1].
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